Skip to main content
. 2023 Nov 6;23:572. doi: 10.1186/s12905-023-02746-w

Table 2.

Gynecological and medical characteristics of the study participants, N = 361

Variable n (%) Bacteria Isolated P value
Yes, N = 107 n (%) No, N = 254 n (%)
Prior infertility treatment 0.199
 Yes 14 (3.9) 2 (1.87) 12 (4.72)
 No 347(96.1) 105 (98.13) 242 (95.28)
Barrier FP method (condoms) n = 112 0.235
 Yes 8 (2.2) 4 (11.43) 4 (5.19)
 No 104 (28.8) 31(88.57) 73 (94.81)
Miscarriage in prior 6 weeks 0.598
 Yes 13 (3.6) 3 (2.80) 10 (3.94)
 No 348 (96.4) 104 (97.20) 244 (96.06)
Prior abnormal vaginal discharge 0.479
 Yes 259 (71.7) 74 (69.16) 185 (72.83)
 No 102 (28.3) 33 (30.84) 69 (27.17)
AVD times in last 6 months 0.324
 None 102 (28.3) 33 (30.84) 69 (27.17)
 Once 137 (38.0) 44 (41.12) 93 (36.61)
 >  = two times 122 (33.8) 30 (28.04) 92 (36.22)
Duration of current abnormal discharge 0.02
 ≤ 7 days 161 (44.6) 45 (42.06) 116 (45.67)
 8–14 days 104 (28.8) 41 (38.32) 63 (24.8)
 More than 14 days 96 (26.6) 21 (19.63) 75 (29.53)
Prior antibiotic use 0.705
 Yes 93 (25.8) 29 (27.1) 64 (25.2)
 No 268 (74.2) 78 (72.9) 190 (74.8)
Long term druga use 0.499
 Yes 109 (30.2) 35 (32.71) 74 (29.13)
 No 252 (69.8) 72 (67.29) 180 (70.87)

FP Family Planning, AVD Abnormal Vaginal Discharge

a Refers to use of antihypertensive or hypoglycemic drugs